Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Martigues

23 clinical trials in Martigues, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Martigues at a glance
23
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

23 trials in Martigues

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apg777
  • Sponsor:Apogee Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Bimekizumab
  • Sponsor:Centre Hospitalier Universitaire De Nice
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Assistance Publique Hopitaux De Paris

Dermatitis atopic

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Lichen sclerosus

Not yet recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:LEO PHARMA A/S

Psoriasis

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Takeda Development Center Americas Inc.

Dermatitis atopic

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Neurodermatitis

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Dermatitis atopic

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apg777
  • Sponsor:Apogee Therapeutics Inc.

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Martigues

What the registry says about research in the country

01 Dermatology - Atopic Dermatitis

Multiple groundbreaking studies evaluating novel treatments for moderate-to-severe atopic dermatitis, including investigations of medications like upadacitinib, lebrikizumab, and nemolizumab. These trials focus on improving disease management and symptom control.

  • Treatment combinations with topical corticosteroids
  • Long-term safety and efficacy studies
  • Novel therapeutic approaches

Research aims to provide better solutions for patients with persistent eczema symptoms.

02 Dermatology - Other Conditions

Innovative clinical research addressing various skin conditions, including psoriasis, vitiligo, and prurigo nodularis. Studies evaluate new therapeutic options targeting specific disease mechanisms.

  • Chronic inflammation management
  • Skin lesion treatments
  • Itch reduction therapies

These trials aim to advance treatment options for challenging dermatological conditions.

03 Hematology & Specialized Care

Advanced research in onco-hematology and other specialized conditions, including studies on multiple myeloma treatment duration and innovative therapies for chronic spontaneous urticaria.

  • Cancer treatment optimization
  • Inflammatory disease management
  • Novel therapeutic approaches

Focused on improving patient outcomes through targeted therapeutic strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.